GCM
GMAB icon

Gallacher Capital Management’s Genmab GMAB Stock Holding History

Gallacher Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
14,240
-7,557
-35% -$201K 0.22% 157
2026
Q1 		$585K Buy
21,797
+232
+1% +$6.95K 0.22% 132
2025
Q4 		$664K Sell
21,565
-106
-0.5% -$3.3K 0.26% 110
2025
Q3 		$665K Buy
21,671
+4,323
+25% +$105K 0.26% 115
2025
Q2 		$358K Buy
17,348
+3,002
+21% +$61.6K 0.17% 180
2025
Q1 		$281K Buy
14,346
+915
+7% +$19.2K 0.14% 201
2024
Q4 		$280K Buy
13,431
+474
+4% +$10.4K 0.14% 205
2024
Q3 		$316K Buy
12,957
+999
+8% +$26.7K 0.15% 192
2024
Q2 		$301K Buy
11,958
+4,093
+52% +$116K 0.16% 184
2024
Q1 		$235K Buy
7,865
+1,192
+18% +$35K 0.12% 218
2023
Q4 		$212K Buy
+6,673
New +$210K 0.12% 238

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Gallacher Capital Management's GMAB Position: Q2 2026 in Review

Gallacher Capital Management reduced its Genmab (GMAB) stake by 35% in Q2 2026, selling an estimated $201K and leaving 14,240 shares worth $391K. The position accounts for 0.22% of the portfolio, ranked #157.

Gallacher Capital Management first reported a position in GMAB in Q4 2023 and has held it in 11 quarters since. The position peaked at $665K in Q3 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Gallacher Capital Management held 14,240 shares of Genmab worth $391K as of Q2 2026.
  • Gallacher Capital Management sold 7,557 Genmab shares in Q2 2026, an estimated $201K.
  • Genmab made up 0.22% of Gallacher Capital Management's portfolio in Q2 2026, its #157 holding.
  • Gallacher Capital Management first reported a position in Genmab in Q4 2023 and has held it in 11 quarters since.
  • Gallacher Capital Management's Genmab position peaked at $665K in Q3 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.